​

Funding Round

Series A - Concerto Biosciences

Series A - Concerto Biosciences

Investment Firm

Overview

Concerto Biosciences reinvents humanity's relationship with microbes.

Announced Date

Mar 22, 2022

Closed on Date

Mar 07, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Safar Partners

Safar Partners

Safar Partners is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorSafar Partners
Participant InvestorM Ventures
Participant InvestorExcelestar Ventures
Participant InvestorHorizons Ventures
Participant InvestorMassVentures

Round Details and Background

Concerto Biosciences raised $24541949 on 2022-03-22 in Series A

Concerto Biosciences reinvents humanity's relationship with microbes.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 02, 2020
Seed Round - Concerto Biosciences
9-1.5M
Mar 22, 2022
Series A - Concerto Biosciences
5-24.5M

Recent Activity

There is no recent news or activity for this profile.